MedPath

on-blinded safety verification test using a dose of the test food "EMFCTR-01" five times higher than that intended for healthy individuals

Not Applicable
Conditions
Healthy person
Registration Number
JPRN-UMIN000019159
Lead Sponsor
Medical Fusion Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

The following exclusion criteria apply to subjects. 1)Use of any prescription drugs or any over-the-counter drugs from -7 day to -1 day before dosing. 2) A person with diseases of the digestive tract, liver, kidney, heart, and circulatory system that might affect test food absorption, distribution, metabolism, and excretion. 3) A person with a lengthy surgical history, including gastrointestinal suture surgery, or intestinal resection. However, polypectomy and appendectomy will not exclude a patient. 4) A person with a history of cerebrovascular disease (asymptomatic lacunar infarction is excluded). 5) A person with tattoo. 6) A person with hypersensitivity or idiosyncrasy, such as food allergies. 7) A person with alcohol or drug dependency. 8) A person who has participated in other clinical trials within 84 days of giving informed consent. 9) A person who has donated 400 ml of blood within 84 days, 200 ml of blood within 28 days, or a blood component (plasma or platelets) within 14 days of giving informed consent. 10) A person trying to become pregnant within the clinical study period. 11) Unable or unwilling to use medically acceptable means of contraception. 12) Nursing or pregnant woman. 13) A person whose diagnosis requires treatment of mental illness by a clinical investigator. 14) A person who is unable to comply with administrative matters during the clinical study. 15) Other people, who are determined ineligible by the clinical investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse events
Secondary Outcome Measures
NameTimeMethod
-Body mass index(BMI) -Blood pressure/pulse/body temperature -General blood test -Biochemical examination -Antioxidative effect and oxidative stress level -Urinalysis -12-lead electrocardiogram -Stool characteristics, stool frequency, stool output -Meal recording
© Copyright 2025. All Rights Reserved by MedPath